Hearing loss in patients with vestibular schwannoma, both before and after treatment, is known to negatively impact quality of life.
TRIO Best Practices » Otology/Neurotology
We review the current evidence to determine if cochlear implantation is an effective intervention for auditory rehabilitation after vestibular schwannoma treatment.
Though some studies show benefit, high-quality data demonstrating the efficacy of betahistine in the treatment of MD is absent.
Current options for hearing rehabilitation offer different advantages to patients with single-sided deafness, and no single modality is clearly superior to the others.
Though the evidence is encouraging, clear causal linkage between hearing loss and cognition has not been established.
Many patients who would likely benefit from implantation are never referred due to poor regional access, and, perhaps most importantly, lack of established CIE referral guidelines.
Sterotactic radiosurgery (SRS) for the treatment of VS can be associated with increased balance symptoms, often within the first six months after treatment.
Cost-effectiveness varies between adults and children.
There is evidence that steroid use may be beneficial to improve hearing preservation.
Betahistine is widely used in Europe and the rest of the world in the treatment of Ménière’s disease.